Literature DB >> 8862073

Safety and long-term efficacy of revisional surgery in severe obesity.

P N Benotti1, R A Forse.   

Abstract

BACKGROUND: A National Institutes of Health Consensus Conference in 1991 established gastric surgery as accepted therapy for the treatment of severe obesity. The increasing prevalence of obesity in the United States, and the increasing numbers of patients undergoing gastric surgery for severe obesity, result in substantial numbers of patients being considered for revisional surgery. The indications and efficacy of revisional surgery remain controversial.
METHODS: Sixty-three patients were followed prospectively after undergoing revisional surgery for obesity between 1981 and 1994. All patients had previously undergone obesity operations. Weight data were recorded at the time of original obesity surgery, at revisional surgery, and at most current follow-up. Complications following revisional surgery were monitored.
RESULTS: The follow-up in the group is 98%. Revisional surgery after obesity surgery was associated with a 0% mortality rate and a serious complication rate of 16%. Body mass index (BMI) at the time of original surgery was 50 +/- 10 kg/m2, at revisional surgery 39 + 9 kg/m2, and at recent follow-up 34 +/- 10 kg/m2 (P < 0.001 vs original BMI). Those patients whose original BMI was > 50 kg/m2 lost significantly more weight (P < 0.0001) than those with an original BMI < 50 kg/m2.
CONCLUSIONS: Revisional gastric surgery is safe and does provide patients with the opportunity to achieve long-term weight control.

Entities:  

Mesh:

Year:  1996        PMID: 8862073     DOI: 10.1016/s0002-9610(96)00160-2

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  20 in total

1.  Roux-en-Y gastric bypass after previous unsuccessful gastric restrictive surgery.

Authors:  Michel Gagner
Journal:  J Gastrointest Surg       Date:  2003 Mar-Apr       Impact factor: 3.452

2.  Laparoscopic adjustable banded roux-en-y gastric bypass as a primary procedure for the super-super-obese (body mass index > 60 kg/m²).

Authors:  Bruno Dillemans; Sebastiaan Van Cauwenberge; Sanjay Agrawal; Els Van Dessel; Jan-Paul Mulier
Journal:  BMC Surg       Date:  2010-11-14       Impact factor: 2.102

3.  Laparoscopic revisional bariatric surgery: myths and facts.

Authors:  R Cohen; J S Pinheiro; J L Correa; C Schiavon
Journal:  Surg Endosc       Date:  2005-05-05       Impact factor: 4.584

Review 4.  Revisional bariatric surgery for inadequate weight loss.

Authors:  Andrew A Gumbs; Alfons Pomp; Michel Gagner
Journal:  Obes Surg       Date:  2007-09       Impact factor: 4.129

5.  Revision of failed bariatric procedures to Roux-en-Y gastric bypass (RYGB).

Authors:  Mousa A Khoursheed; Ibtisam A Al-Bader; Fahad S Al-asfar; Ali I Mohammad; Mumtaz Shukkur; Hussain M Dashti
Journal:  Obes Surg       Date:  2011-08       Impact factor: 4.129

6.  Laparoscopic Roux-en-Y Gastric bypass after failed vertical banded gastroplasty: a multicenter experience with 203 patients.

Authors:  M Suter; S Ralea; P Millo; J L Allé
Journal:  Obes Surg       Date:  2012-10       Impact factor: 4.129

7.  Laparoscopic gastric bypass as a reoperative bariatric surgery for failed open restrictive procedures.

Authors:  J de Csepel; R Nahouraii; M Gagner
Journal:  Surg Endosc       Date:  2001-02-06       Impact factor: 4.584

8.  Roux-en-Y gastric bypass after previous unsuccessful gastric restrictive surgery.

Authors:  Agneta Westling; Màrgàretà Ohrvall; Sven Gustavsson
Journal:  J Gastrointest Surg       Date:  2002 Mar-Apr       Impact factor: 3.452

9.  Conversion of proximal to distal gastric bypass for failed gastric bypass for superobesity.

Authors:  H J Sugerman; J M Kellum; E J DeMaria
Journal:  J Gastrointest Surg       Date:  1997 Nov-Dec       Impact factor: 3.452

10.  Conversion of vertical banded gastroplasty to Roux-en-Y gastric bypass results in restoration of the positive effect on weight loss and co-morbidities: evaluation of 101 patients.

Authors:  Ruben Schouten; Francois M H van Dielen; Wim G van Gemert; Jan Willem M Greve
Journal:  Obes Surg       Date:  2007-05       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.